{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:13:24Z","timestamp":1791562404130,"version":"4.3.4"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T00:00:00Z","timestamp":1601337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T00:00:00Z","timestamp":1601337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s13760-020-01509-w","type":"journal-article","created":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T20:03:00Z","timestamp":1601409780000},"page":"1307-1321","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Montreal cognitive assessment for evaluating cognitive impairment in multiple sclerosis: a systematic review"],"prefix":"10.1007","volume":"120","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2412-1942","authenticated-orcid":false,"given":"Elena Cecilia","family":"Rosca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihaela","family":"Simu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,29]]},"reference":[{"key":"1509_CR1","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/00019052-199906000-00008","volume":"12","author":"BD Trapp","year":"1999","unstructured":"Trapp BD, Ransohoff R, Rudick R (1999) Axonal pathology in multiple sclerosis: relationship to neurologic disability. Curr Opin Neurol 12:295\u2013302. https:\/\/doi.org\/10.1097\/00019052-199906000-00008","journal-title":"Curr Opin Neurol"},{"key":"1509_CR2","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/S1474-4422(08)70259-X","volume":"7","author":"ND Chiaravalloti","year":"2008","unstructured":"Chiaravalloti ND, DeLuca J (2008) Cognitive impairment in multiple sclerosis. Lancet Neurol 7:1139\u20131151. https:\/\/doi.org\/10.1016\/S1474-4422(08)70259-X","journal-title":"Lancet Neurol"},{"issue":"1","key":"1509_CR3","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3390\/ijms18010046","volume":"18","author":"X Zhang","year":"2017","unstructured":"Zhang X, Zhang F, Huang D et al (2017) Contribution of gray and white matter abnormalities to cognitive impairment in multiple sclerosis. Int J Mol Sci 18(1):46. https:\/\/doi.org\/10.3390\/ijms18010046","journal-title":"Int J Mol Sci"},{"key":"1509_CR4","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1212\/wnl.41.5.685","volume":"41","author":"SM Rao","year":"1991","unstructured":"Rao SM, Leo GJ, Bernardin L, Unverzagt F (1991) Cognitive dysfunction in multiple sclerosis: frequency, patterns, and prediction. Neurology 41:685\u2013691. https:\/\/doi.org\/10.1212\/wnl.41.5.685","journal-title":"Neurology"},{"key":"1509_CR5","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1212\/WNL.0000000000004977","volume":"90","author":"JF Sumowski","year":"2018","unstructured":"Sumowski JF, Benedict R, Enzinger C, Filippi M, Geurts JJ, Hamalainen P et al (2018) Cognition in multiple sclerosis: state of the field and priorities for the future. Neurology 90:278\u2013288. https:\/\/doi.org\/10.1212\/WNL.0000000000004977","journal-title":"Neurology"},{"key":"1509_CR6","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1001\/archneur.58.10.1602","volume":"58","author":"MP Amato","year":"2001","unstructured":"Amato MP, Ponziani G, Siracusa G et al (2001) Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years. Arch Neurol 58:1602\u20131606. https:\/\/doi.org\/10.1001\/archneur.58.10.1602","journal-title":"Arch Neurol"},{"key":"1509_CR7","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1212\/WNL.0b013e3182918c6f","volume":"80","author":"MP Amato","year":"2013","unstructured":"Amato MP, Razzolini L, Goretti B et al (2013) Cognitive reserve and cortical atrophy in multiple sclerosis: a longitudinal study. Neurology 80:1728\u20131733. https:\/\/doi.org\/10.1212\/WNL.0b013e3182918c6f","journal-title":"Neurology"},{"key":"1509_CR8","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1177\/1352458513485981","volume":"19","author":"M Lacy","year":"2013","unstructured":"Lacy M, Hauser M, Pliskin N et al (2013) The effects of long-term interferon-beta-1b treatment on cognitive functioning in multiple sclerosis: a 16-year longitudinal study. Mult Scler 19:1765\u20131772. https:\/\/doi.org\/10.1177\/1352458513485981","journal-title":"Mult Scler"},{"key":"1509_CR9","doi-asserted-by":"publisher","first-page":"e71058","DOI":"10.1371\/journal.pone.0071058","volume":"8","author":"A Achiron","year":"2013","unstructured":"Achiron A, Chapman J, Magalashvili D, Dolev M, Lavie M, Bercovich E et al (2013) Modeling of cognitive impairment by disease duration in multiple sclerosis: a cross-sectional study. PLoS ONE 8:e71058. https:\/\/doi.org\/10.1371\/journal.pone.0071058","journal-title":"PLoS ONE"},{"key":"1509_CR10","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3389\/fneur.2019.00261","volume":"10","author":"B Brochet","year":"2019","unstructured":"Brochet B, Ruet A (2019) Cognitive impairment in multiple sclerosis with regards to disease duration and clinical phenotypes. Front Neurol 10:261. https:\/\/doi.org\/10.3389\/fneur.2019.00261","journal-title":"Front Neurol"},{"issue":"13","key":"1509_CR11","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1177\/1352458518803785","volume":"24","author":"R Kalb","year":"2018","unstructured":"Kalb R, Beier M, Benedict RH et al (2018) Recommendations for cognitive screening and management in multiple sclerosis care. Mult Scler 24(13):1665\u20131680. https:\/\/doi.org\/10.1177\/1352458518803785","journal-title":"Mult Scler"},{"key":"1509_CR12","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1177\/1352458510380089","volume":"16","author":"MP Amato","year":"2010","unstructured":"Amato MP, Portaccio E, Goretti B et al (2010) Relevance of cognitive deterioration in early relapsing remitting MS: a 3-year follow-up study. Mult Scler 16:1474\u20131482. https:\/\/doi.org\/10.1177\/1352458510380089","journal-title":"Mult Scler"},{"key":"1509_CR13","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1177\/1352458510375707","volume":"16","author":"C Lebrun","year":"2010","unstructured":"Lebrun C, Blanc F, Brassat D, Zephir H, de Seze J, CFSEP (2010) Cognitive function in radiologically isolated syndrome. Mult Scler 16:919\u2013925. https:\/\/doi.org\/10.1177\/1352458510375707","journal-title":"Mult Scler"},{"key":"1509_CR14","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1212\/WNL.0b013e31824528c9","volume":"78","author":"MP Amato","year":"2012","unstructured":"Amato MP, Hakiki B, Goretti B, Rossi F, Stromillo ML, Giorgio A et al (2012) Association of MRI metrics and cognitive impairment in radiologically isolated syndromes. Neurology 78:309\u2013314. https:\/\/doi.org\/10.1212\/WNL.0b013e31824528c9","journal-title":"Neurology"},{"key":"1509_CR15","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1177\/1352458510384009","volume":"17","author":"M Khalil","year":"2011","unstructured":"Khalil M, Enzinger C, Langkammer C, Petrovic K, Loitfelder M, Tscherner M et al (2011) Cognitive impairment in relation to MRI metrics in patients with clinically isolated syndrome. Mult Scler 17:173\u2013180. https:\/\/doi.org\/10.1177\/1352458510384009","journal-title":"Mult Scler"},{"key":"1509_CR16","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1177\/1352458511398265","volume":"17","author":"F Reuter","year":"2011","unstructured":"Reuter F, Zaaraoui W, Crespy L, Faivre A, Rico A, Malikova I et al (2011) Cognitive impairment at the onset of multiple sclerosis: relationship to lesion location. Mult Scler 17:755\u2013758. https:\/\/doi.org\/10.1177\/1352458511398265","journal-title":"Mult Scler"},{"key":"1509_CR17","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1155\/2012\/105471","volume":"25","author":"T Panou","year":"2012","unstructured":"Panou T, Mastorodemos V, Papadaki E, Simos PG, Plaitakis A (2012) Early signs of memory impairment among multiple sclerosis patients with clinically isolated syndrome. Behav Neurol 25:311\u2013326. https:\/\/doi.org\/10.1155\/2012\/105471","journal-title":"Behav Neurol"},{"key":"1509_CR18","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1177\/1352458516674367","volume":"23","author":"L Ruano","year":"2017","unstructured":"Ruano L, Portaccio E, Goretti B, Niccolai C, Severo M, Patti F et al (2017) Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes. Mult Scler 23:1258\u20131267. https:\/\/doi.org\/10.1177\/1352458516674367","journal-title":"Mult Scler"},{"issue":"2","key":"1509_CR19","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1177\/1352458518813108","volume":"26","author":"I Koubiyr","year":"2020","unstructured":"Koubiyr I, Deloire M, Besson P et al (2020) Longitudinal study of functional brain network reorganization in clinically isolated syndrome. Mult Scler 26(2):188\u2013200. https:\/\/doi.org\/10.1177\/1352458518813108","journal-title":"Mult Scler"},{"key":"1509_CR20","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/ene.12715","volume":"23","author":"V Planche","year":"2016","unstructured":"Planche V, Gibelin M, Cregut D, Pereira B, Clavelou P (2016) Cognitive impairment in a population-based study of patients with multiple sclerosis: differences between late relapsing-remitting, secondary progressive and primary progressive multiple sclerosis. Eur J Neurol 23:282\u2013289. https:\/\/doi.org\/10.1111\/ene.12715","journal-title":"Eur J Neurol"},{"issue":"7","key":"1509_CR21","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1093\/brain\/122.7.1341","volume":"122","author":"SJ Camp","year":"1999","unstructured":"Camp SJ, Stevenson VL, Thompson AJ, Miller DH, Borras C, Auriacombe S et al (1999) Cognitive function in primary progressive and transitional progressive multiple sclerosis: a controlled study with MRI correlates. Brain 122(7):1341\u20131348. https:\/\/doi.org\/10.1093\/brain\/122.7.1341","journal-title":"Brain"},{"key":"1509_CR22","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jns.2007.10.002","volume":"267","author":"C Potagas","year":"2008","unstructured":"Potagas C, Giogkaraki E, Koutsis G, Mandellos D, Tsirempolou E, Sfagos C et al (2008) Cognitive impairment in different MS subtypes and clinically isolated syndromes. J Neurol Sci 267:100\u2013106. https:\/\/doi.org\/10.1016\/j.jns.2007.10.002","journal-title":"J Neurol Sci"},{"key":"1509_CR23","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1212\/WNL.0b013e31828cf82f","volume":"80","author":"A Ruet","year":"2013","unstructured":"Ruet A, Deloire M, Charr\u00e9-Morin J, Hamel D, Brochet B (2013) Cognitive impairment differs between primary progressive and relapsing-remitting MS. Neurology 80:1501\u20131508. https:\/\/doi.org\/10.1212\/WNL.0b013e31828cf82f","journal-title":"Neurology"},{"key":"1509_CR24","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1007\/s00415-011-5975-3","volume":"258","author":"SA Morrow","year":"2011","unstructured":"Morrow SA, Jurgensen S, Forrestal F et al (2011) Effects of acute relapses on neuropsychological status in multiple sclerosis patients. J Neurol 258:1603\u20131608. https:\/\/doi.org\/10.1007\/s00415-011-5975-3","journal-title":"J Neurol"},{"key":"1509_CR25","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1136\/jnnp-2013-307275","volume":"85","author":"M Pardini","year":"2014","unstructured":"Pardini M, Uccelli A, Grafman J et al (2014) Isolated cognitive relapses in multiple sclerosis. J Neurol Neurosurg Psychiatry 85:1035\u20131037. https:\/\/doi.org\/10.1136\/jnnp-2013-307275","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1509_CR26","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1177\/1352458517690821","volume":"23","author":"R Benedict","year":"2017","unstructured":"Benedict R, DeLuca J, Phillips G, LaRocca N, Hudson LD, Rudick R, Multiple Sclerosis Outcome Assessments Consortium (2017) Validity of the symbol digit modalities test as a cognition performance outcome measure for multiple sclerosis. Mult Scler 23:721\u2013733. https:\/\/doi.org\/10.1177\/1352458517690821","journal-title":"Mult Scler"},{"key":"1509_CR27","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1017\/s1355617706060723","volume":"12","author":"RHB Benedict","year":"2006","unstructured":"Benedict RHB, Cookfair D, Gavett R et al (2006) Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS). J Int Neuropsychol Soc 12:549\u2013558. https:\/\/doi.org\/10.1017\/s1355617706060723","journal-title":"J Int Neuropsychol Soc"},{"key":"1509_CR28","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1177\/1352458516688955","volume":"23","author":"SM Rao","year":"2017","unstructured":"Rao SM, Losinski G, Mourany L et al (2017) Processing speed test: validation of a self-administered, iPad\u00ae-based tool for screening cognitive dysfunction in a clinic setting. Mult Scler 23:1929\u20131937. https:\/\/doi.org\/10.1177\/1352458516688955","journal-title":"Mult Scler"},{"key":"1509_CR29","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1177\/1352458513480251","volume":"19","author":"A Ruet","year":"2013","unstructured":"Ruet A, Deloire MSA, Charr\u00e9-Morin J et al (2013) A new computerised cognitive test for the detection of information processing speed impairment in multiple sclerosis. Mult Scler 19:1665\u20131672. https:\/\/doi.org\/10.1177\/1352458513480251","journal-title":"Mult Scler"},{"key":"1509_CR30","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1191\/1352458504ms1098oa","volume":"10","author":"RHB Benedict","year":"2004","unstructured":"Benedict RHB, Cox D, Thompson LL et al (2004) Reliable screening for neuropsychological impairment in multiple sclerosis. Mult Scler 10:675\u2013678. https:\/\/doi.org\/10.1191\/1352458504ms1098oa","journal-title":"Mult Scler"},{"key":"1509_CR31","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.acn.2007.07.002","volume":"22","author":"A O\u2019Brien","year":"2007","unstructured":"O\u2019Brien A, Gaudino-Goering E, Shawaryn M et al (2007) Relationship of the multiple sclerosis neuropsychological questionnaire (MSNQ) to functional, emotional, and neuropsychological outcomes. Arch Clin Neuropsychol 22:933\u2013948. https:\/\/doi.org\/10.1016\/j.acn.2007.07.002","journal-title":"Arch Clin Neuropsychol"},{"key":"1509_CR32","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1097\/WNN.0b013e31822a20ae","volume":"24","author":"N Akbar","year":"2011","unstructured":"Akbar N, Honarmand K, Feinstein A (2011) Self-assessment of cognition in multiple sclerosis: the role of personality and anxiety. Cogn Behav Neurol 24:115\u2013121. https:\/\/doi.org\/10.1097\/WNN.0b013e31822a20ae","journal-title":"Cogn Behav Neurol"},{"key":"1509_CR33","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1177\/1352458511431076","volume":"18","author":"DW Langdon","year":"2012","unstructured":"Langdon DW, Amato MP, Boringa J et al (2012) Recommendations for a brief international cognitive assessment for multiple sclerosis (BICAMS). Mult Scler 18:891\u2013898. https:\/\/doi.org\/10.1177\/1352458511431076","journal-title":"Mult Scler"},{"key":"1509_CR34","doi-asserted-by":"publisher","first-page":"e13300","DOI":"10.1111\/ijcp.13300","volume":"73","author":"OA Klein","year":"2019","unstructured":"Klein OA, das Nair R, Ablewhite J, Drummond A (2019) Assessment and management of cognitive problems in people with multiple sclerosis: a national survey of clinical practice. Int J Clin Pract 73:e13300. https:\/\/doi.org\/10.1111\/ijcp.13300","journal-title":"Int J Clin Pract"},{"key":"1509_CR35","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s11065-019-09408-5","volume":"29","author":"S Paul","year":"2019","unstructured":"Paul S, Brown A, Hughes AJ (2019) Cognitive assessment of individuals with multiple sclerosis in the Arab world: a systematic review. Neuropsychol Rev 29:259\u2013269. https:\/\/doi.org\/10.1007\/s11065-019-09408-5","journal-title":"Neuropsychol Rev"},{"issue":"4","key":"1509_CR36","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H (2005) The montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53(4):695\u2013699. https:\/\/doi.org\/10.1111\/j.1532-5415.2005.53221.x","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"1509_CR37","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1159\/000340006","volume":"33","author":"AS Costa","year":"2012","unstructured":"Costa AS, Fimm B, Friesen P, Soundjock H, Rottschy C, Gross T, Eitner F, Reich A, Schulz JB, Nasreddine ZS, Reetz K (2012) Alternate-form reliability of the montreal cognitive assessment screening test in a clinical setting. Dement Geriatr Cogn Disord 33(6):379\u2013384. https:\/\/doi.org\/10.1159\/000340006","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"2","key":"1509_CR38","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/gps.2306","volume":"25","author":"Z Ismail","year":"2010","unstructured":"Ismail Z, Rajji TK, Shulman KI (2010) Brief cognitive screening instruments: an update. Int J of Geriatr Psychiatry 25(2):111\u2013120. https:\/\/doi.org\/10.1002\/gps.2306","journal-title":"Int J of Geriatr Psychiatry"},{"issue":"1","key":"1509_CR39","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/WAD.0b013e3182420bfe","volume":"27","author":"S Freitas","year":"2013","unstructured":"Freitas S, Simoes MR, Alves L, Santana I (2013) Montreal cognitive assessment: validation study for mild cognitive impairment and alzheimer disease. Alzheimer Dis Assoc Disord 27(1):37\u201343. https:\/\/doi.org\/10.1097\/WAD.0b013e3182420bfe","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"21","key":"1509_CR40","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1212\/WNL.0b013e3181e7948a","volume":"73","author":"S Hoops","year":"2009","unstructured":"Hoops S, Nazem S, Siderowf AD, Duda JE, Xie SX, Stern MB, Weintraub D (2009) Validity of the MoCA and MMSE in the detection of MCI and dementia in parkinson disease. Neurology 73(21):1738\u20131745. https:\/\/doi.org\/10.1212\/WNL.0b013e3181e7948a","journal-title":"Neurology"},{"issue":"1","key":"1509_CR41","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1080\/09084282.2012.670158","volume":"20","author":"O Bezdicek","year":"2013","unstructured":"Bezdicek O, Majerova V, Novak M, Nikolai T, Ruzicka E, Roth J (2013) Validity of the montreal cognitive assessment in the detection of cognitive dysfunction in huntington's disease. Appl Neuropsychol Adult 20(1):33\u201340. https:\/\/doi.org\/10.1080\/09084282.2012.670158","journal-title":"Appl Neuropsychol Adult"},{"issue":"10","key":"1509_CR42","doi-asserted-by":"publisher","first-page":"3008","DOI":"10.1161\/STROKEAHA.114.005842","volume":"45","author":"R Lees","year":"2014","unstructured":"Lees R, Selvarajah J, Fenton C, Pendlebury ST, Langhorne P, Stott DJ, Quinn TJ (2014) Test accuracy of cognitive screening tests for diagnosis of dementia and multidomain cognitive impairment in stroke. Stroke 45(10):3008\u20133018. https:\/\/doi.org\/10.1161\/STROKEAHA.114.005842","journal-title":"Stroke"},{"key":"1509_CR43","doi-asserted-by":"publisher","first-page":"CD010775","DOI":"10.1002\/14651858.CD010775.pub2","volume":"10","author":"DH Davis","year":"2015","unstructured":"Davis DH, Creavin ST, Yip JL, Noel-Storr AH, Brayne C, Cullum S (2015) Montreal cognitive assessment for the diagnosis of Alzheimer's disease and other dementias. Cochrane Database Syst Rev 10:CD010775. https:\/\/doi.org\/10.1002\/14651858.CD010775.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"1509_CR44","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/gps.4756","volume":"33","author":"N Carson","year":"2018","unstructured":"Carson N, Leach L, Murphy KJ (2018) A re-examination of montreal cognitive assessment (MoCA) cutoff scores. Int J Geriatr Psychiatry 33(2):379\u2013388. https:\/\/doi.org\/10.1002\/gps.4756","journal-title":"Int J Geriatr Psychiatry"},{"issue":"3","key":"1509_CR45","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s11065-019-09412-9","volume":"29","author":"EC Rosca","year":"2019","unstructured":"Rosca EC, Albarqouni L, Simu M (2019) Montreal cognitive assessment (MoCA) for HIV-associated neurocognitive disorders. Neuropsychol Rev 29(3):313\u2013327. https:\/\/doi.org\/10.1007\/s11065-019-09412-9","journal-title":"Neuropsychol Rev"},{"key":"1509_CR46","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.genhosppsych.2020.05.011","volume":"65","author":"EC Rosca","year":"2020","unstructured":"Rosca EC, Cornea A, Simu M (2020) Montreal cognitive assessment for evaluating the cognitive impairment in patients with schizophrenia: a systematic review. Gen Hosp Psychiatry 65:64\u201373. https:\/\/doi.org\/10.1016\/j.genhosppsych.2020.05.011","journal-title":"Gen Hosp Psychiatry"},{"key":"1509_CR47","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/S1474-4422(14)70250-9","volume":"14","author":"MA Rocca","year":"2015","unstructured":"Rocca MA, Amato MP, De Stefano N et al (2015) Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis. Lancet Neurol 14:302\u2013317. https:\/\/doi.org\/10.1016\/S1474-4422(14)70250-9","journal-title":"Lancet Neurol"},{"key":"1509_CR48","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1177\/1352458514533229","volume":"20","author":"RH Benedict","year":"2014","unstructured":"Benedict RH, Morrow S, Rodgers J et al (2014) Characterizing cognitive function during relapse in multiple sclerosis. Mult Scler 20:1745\u20131752. https:\/\/doi.org\/10.1177\/1352458514533229","journal-title":"Mult Scler"},{"issue":"1","key":"1509_CR49","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s12883-018-1224-z","volume":"18","author":"G Fenu","year":"2018","unstructured":"Fenu G, Fronza M, Lorefice L, Arru M, Coghe G, Frau J et al (2018) Performance in daily activities, cognitive impairment and perception in multiple sclerosis patients and their caregivers. BMC Neurol 18(1):212. https:\/\/doi.org\/10.1186\/s12883-018-1224-z","journal-title":"BMC Neurol"},{"issue":"1","key":"1509_CR50","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s10072-008-0009-3","volume":"30","author":"B Goretti","year":"2009","unstructured":"Goretti B, Portaccio E, Zipoli V, Hakiki B, Siracusa G, Sorbi S et al (2009) Coping strategies, psychological variables and their relationship with quality of life in multiple sclerosis. Neurol Sci 30(1):15\u201320. https:\/\/doi.org\/10.1007\/s10072-008-0009-3","journal-title":"Neurol Sci"},{"issue":"2","key":"1509_CR51","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.apmr.2017.07.021","volume":"99","author":"Y Goverover","year":"2018","unstructured":"Goverover Y, Chiaravalloti ND, O'Brien AR, DeLuca J (2018) Evidenced-based cognitive rehabilitation for persons with multiple sclerosis: An updated review of the literature from 2007 to 2016. Arch Phys Med Rehabil 99(2):390\u2013407. https:\/\/doi.org\/10.1016\/j.apmr.2017.07.021","journal-title":"Arch Phys Med Rehabil"},{"key":"1509_CR52","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40893-017-0025-3","volume":"2","author":"C Niccolai","year":"2017","unstructured":"Niccolai C, Goretti B, Amato MP (2017) Disease modifying treatments and symptomatic drugs for cognitive impairment in multiple sclerosis: where do we stand? Mult Scler Demyelinating Disord 2:8. https:\/\/doi.org\/10.1186\/s40893-017-0025-3","journal-title":"Mult Scler Demyelinating Disord"},{"key":"1509_CR53","unstructured":"Handbook for Diagnostic Test Accuracy Reviews. https:\/\/methods.cochrane.org\/sdt\/handbook-dta-reviews . Accessed 18 April 2020."},{"issue":"7","key":"1509_CR54","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, the PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097. https:\/\/doi.org\/10.1371\/journal.pmed.1000097","journal-title":"PLoS Med"},{"issue":"6","key":"1509_CR55","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1002\/ana.20703","volume":"58","author":"CH Polman","year":"2005","unstructured":"Polman CH, Reingold SC, Edan G et al (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the \"McDonald Criteria\". Ann Neurol 58(6):840\u2013846. https:\/\/doi.org\/10.1002\/ana.20703","journal-title":"Ann Neurol"},{"issue":"3","key":"1509_CR56","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1097\/XEB.0000000000000061","volume":"13","author":"JM Campbell","year":"2015","unstructured":"Campbell JM, Klugar M, Ding S, Carmody D, Hakonsen SJ, Jadotte YT et al (2015) Diagnostic test accuracy. Int J Evid Based Healthc 13(3):154\u2013162. https:\/\/doi.org\/10.1097\/XEB.0000000000000061","journal-title":"Int J Evid Based Healthc"},{"key":"1509_CR57","doi-asserted-by":"publisher","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","volume":"155","author":"PF Whiting","year":"2011","unstructured":"Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB et al (2011) QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155:529\u2013536. https:\/\/doi.org\/10.7326\/0003-4819-155-8-201110180-00009","journal-title":"Ann Intern Med"},{"issue":"3","key":"1509_CR58","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1017\/s0317167100014384","volume":"40","author":"E Dagenais","year":"2013","unstructured":"Dagenais E, Rouleau I, Demers M et al (2013) Value of the MoCA test as a screening instrument in multiple sclerosis. Can J Neurol Sci 40(3):410\u2013415. https:\/\/doi.org\/10.1017\/s0317167100014384","journal-title":"Can J Neurol Sci"},{"issue":"19","key":"1509_CR59","doi-asserted-by":"publisher","first-page":"30149","DOI":"10.1016\/j.nrl.2019.11.006","volume":"S0213\u20134853","author":"SM Gomez-Moreno","year":"2020","unstructured":"Gomez-Moreno SM, Cuadrado ML, Cruz-Ordu\u00f1a I et al (2020) Validation of the Spanish-language version of the montreal cognitive assessment as a screening test for cognitive impairment in multiple sclerosis. Neurologia S0213\u20134853(19):30149\u201330155. https:\/\/doi.org\/10.1016\/j.nrl.2019.11.006","journal-title":"Neurologia"},{"key":"1509_CR60","doi-asserted-by":"publisher","DOI":"10.1017\/cjn.2020.97","author":"K Charest","year":"2020","unstructured":"Charest K, Tremblay A, Langlois R, Roger \u00c9, Duquette P, Rouleau I (2020) Detecting subtle cognitive impairment in multiple sclerosis with the MoCA test. Can J Neurol Sci. https:\/\/doi.org\/10.1017\/cjn.2020.97","journal-title":"Can J Neurol Sci"},{"issue":"1","key":"1509_CR61","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1080\/23279095.2016.1243108","volume":"25","author":"S Freitas","year":"2018","unstructured":"Freitas S, Batista S, Afonso AC et al (2018) The montreal cognitive assessment (MoCA) as a screening test for cognitive dysfunction in multiple sclerosis. Appl Neuropsychol Adult 25(1):57\u201370. https:\/\/doi.org\/10.1080\/23279095.2016.1243108","journal-title":"Appl Neuropsychol Adult"},{"key":"1509_CR62","doi-asserted-by":"publisher","DOI":"10.1080\/23279095.2019.1588123","author":"K Konstantopoulos","year":"2019","unstructured":"Konstantopoulos K, Vogazianos P (2019) Montreal cognitive assessment in a Greek sample of patients with multiple sclerosis: a validation study. Appl Neuropsychol Adult. https:\/\/doi.org\/10.1080\/23279095.2019.1588123","journal-title":"Appl Neuropsychol Adult"},{"issue":"4","key":"1509_CR63","doi-asserted-by":"publisher","first-page":"137","DOI":"10.22037\/icnj.v2i4.11665","volume":"2","author":"MA Ahmadi","year":"2015","unstructured":"Ahmadi MA, Ashrafi F, Behnam B (2015) Comparison of montreal cognitive assessment test and mini mental state examination in detecting cognitive impairment in relapsing-remitting multiple sclerosis patients. Int Clin Neurosci J 2(4):137\u2013141. https:\/\/doi.org\/10.22037\/icnj.v2i4.11665","journal-title":"Int Clin Neurosci J"},{"issue":"1","key":"1509_CR64","first-page":"2","volume":"44","author":"PK Abraham","year":"2012","unstructured":"Abraham PK, Rege PV (2012) A study of cognitive impairments in multiple sclerosis: occupational therapy perspective. Indian J Occup Ther 44(1):2\u201312","journal-title":"Indian J Occup Ther"},{"issue":"2","key":"1509_CR65","doi-asserted-by":"publisher","first-page":"52","DOI":"10.4274\/Tnd.86570","volume":"19","author":"S Aksoy","year":"2013","unstructured":"Aksoy S, Timer E, Mumcu S et al (2013) Screening for cognitive impairment in multiple sclerosis with MOCA test. Turk Noroloji Dergisi 19(2):52\u201355. https:\/\/doi.org\/10.4274\/Tnd.86570","journal-title":"Turk Noroloji Dergisi"},{"issue":"7","key":"1509_CR66","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1177\/1352458514531864","volume":"20","author":"NS Billore","year":"2014","unstructured":"Billore NS, Kumar G, Kaur D, Singh AK (2014) Screening cognitive impairments in Indian ms patients through oral version of symbol digit modality test and montreal cognitive assessment test. Mult Scler 20(7):918. https:\/\/doi.org\/10.1177\/1352458514531864","journal-title":"Mult Scler"},{"key":"1509_CR67","unstructured":"Lopez GR, Leal IRO, Perodin MP (2014) cognitive changes on the multiple sclerosis. Revista del Hospital Psiquiatrico de la Habana 11(2). https:\/\/www.scopus.com"},{"key":"1509_CR68","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4172\/2376-0389.1000135","volume":"2","author":"LE Charvet","year":"2015","unstructured":"Charvet LE, Taub E, Cersosimo B et al (2015) The montreal cognitive assessment (MoCA) in multiple sclerosis: relation to clinical features. J Mult Scler 2:2. https:\/\/doi.org\/10.4172\/2376-0389.1000135","journal-title":"J Mult Scler"},{"issue":"3","key":"1509_CR69","doi-asserted-by":"publisher","first-page":"109","DOI":"10.4274\/tnd.46704","volume":"22","author":"HS Sengul","year":"2016","unstructured":"Sengul HS, Seng\u00fcl Y, Y\u00fccel S, Forta H (2016) Cognitive impairment in young multiple sclerosis and essential tremor patients: a comparative study. Turk Noroloji Dergisi 22(3):109\u2013113. https:\/\/doi.org\/10.4274\/tnd.46704","journal-title":"Turk Noroloji Dergisi"},{"issue":"3","key":"1509_CR70","doi-asserted-by":"publisher","first-page":"168","DOI":"10.4103\/1110-1083.193067","volume":"53","author":"E-SA Tag El-Din","year":"2016","unstructured":"Tag El-Din E-SA, Bahnasy WS, Rashed KH et al (2016) Cognitive functions in multiple sclerosis patients. Egypt J Neurol Psychiatr Neurosurg 53(3):168\u2013173. https:\/\/doi.org\/10.4103\/1110-1083.193067","journal-title":"Egypt J Neurol Psychiatr Neurosurg"},{"key":"1509_CR71","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.jns.2019.10.1355","volume":"405","author":"I Ganieva","year":"2019","unstructured":"Ganieva I, Parpieva Y, Khalimova K, Yakubova M (2019) The study of the of cognitive disfunctions using to the test \u201cMoCa\u201d in patients with multiple sclerosis. J Neurol Sci 405:284. https:\/\/doi.org\/10.1016\/j.jns.2019.10.1355","journal-title":"J Neurol Sci"},{"key":"1509_CR72","doi-asserted-by":"publisher","first-page":"189","DOI":"10.7326\/0003-4819-140-3-200402030-00010","volume":"140","author":"P Whiting","year":"2004","unstructured":"Whiting P, Rutjes AW, Reitsma JB, Glas AS, Bossuyt PM, Kleijnen J (2004) Sources of variation and bias in studies of diagnostic accuracy: a systematic review. Ann Intern Med 140:189\u2013202. https:\/\/doi.org\/10.7326\/0003-4819-140-3-200402030-00010","journal-title":"Ann Intern Med"},{"key":"1509_CR73","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1159\/000095858","volume":"22","author":"T Del Ser","year":"2006","unstructured":"Del Ser T, Sanchez-Sanchez F, Garcia de Yebenes MJ, Otero A, Munoz DG (2006) Validation of the seven-minute screen neurocognitive battery for the diagnosis of dementia in a Spanish population-based sample. Dement Geriatr Cogn Disord 22:454\u2013464. https:\/\/doi.org\/10.1159\/000095858","journal-title":"Dement Geriatr Cogn Disord"},{"key":"1509_CR74","unstructured":"Bezd\u0131cek O, Balabanova P, Havrankova P, Stochl J, Roth J, Ruzicka E (2010) Comparison of the Czech version of the montreal cognitive assessment test with the mini-mental state examination in identifying cognitive deficits in parkinson\u2019s disease. Czech and Slovak Neurology and Neurosurgery 73:150\u2013156. https:\/\/www.csnn.eu\/en\/journals\/czech-and-slovak-neurology-and-neurosurgery\/2010-2\/a-comparison-of-the-czech-version-of-the-montreal-cognitive-assessment-test-with-the-mini-mental-state-examination-in-identifying-cognitive-deficits-in-parkinsons-disease-33828Accessed 26 Sept (2020)"},{"key":"1509_CR75","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/978-1-4471-2452-8_6","volume-title":"Cognitive Screening Instruments","author":"P Julayanont","year":"2013","unstructured":"Julayanont P, Phillips N, Chertkow H, Nasreddine ZS (2013) Montreal Cognitive Assessment (MoCA): Concept and Clinical Review. In: Larner A (ed) Cognitive Screening Instruments. Springer, London, pp 111\u2013151. https:\/\/doi.org\/10.1007\/978-1-4471-2452-8_6"},{"key":"1509_CR76","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jocn.2016.02.038","volume":"33","author":"AM Novo","year":"2016","unstructured":"Novo AM, Batista S, Tenente J et al (2016) Apathy in multiple sclerosis: gender matters. J Clin Neurosci 33:100\u2013104. https:\/\/doi.org\/10.1016\/j.jocn.2016.02.038","journal-title":"J Clin Neurosci"},{"key":"1509_CR77","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.msard.2018.10.112","volume":"27","author":"EK Cehelyk","year":"2019","unstructured":"Cehelyk EK, Harvey DY, Grubb ML et al (2019) Uncovering the association between fatigue and fatigability in multiple sclerosis using cognitive control. Mult Scler Relat Disord 27:269\u2013275. https:\/\/doi.org\/10.1016\/j.msard.2018.10.112","journal-title":"Mult Scler Relat Disord"},{"issue":"7","key":"1509_CR78","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1093\/ptj\/pzx044","volume":"97","author":"H Khalil","year":"2017","unstructured":"Khalil H, Al-Shorman A, El-Salem K et al (2017) Fear of falling in people with multiple sclerosis: which clinical characteristics are important? Phys Ther 97(7):698\u2013706. https:\/\/doi.org\/10.1093\/ptj\/pzx044","journal-title":"Phys Ther"},{"issue":"1","key":"1509_CR79","first-page":"11","volume":"16","author":"V Vacaras","year":"2014","unstructured":"Vacaras V, Major ZZ, Seewooram R, Major KA, Muresanu DF, Buzoianu AD (2014) Disease activity and disability evolution under glatiramer acetate: a clinical approach. Neuropsychopharmacol Hung 16(1):11\u201318 (PMID: 24687014)","journal-title":"Neuropsychopharmacol Hung"},{"issue":"Suppl 16","key":"1509_CR80","doi-asserted-by":"crossref","first-page":"P5.356","DOI":"10.1212\/WNL.88.16_supplement.P5.356","volume":"88","author":"R Berkovich","year":"2017","unstructured":"Berkovich R (2017) Effects of alemtuzumab on disability and cognition in patients with secondary progressive multiple sclerosis (SPMS). Neurology 88(Suppl 16):P5.356","journal-title":"Neurology"},{"key":"1509_CR81","doi-asserted-by":"publisher","first-page":"45926","DOI":"10.1038\/srep45926","volume":"7","author":"H Darwish","year":"2017","unstructured":"Darwish H, Haddad R, Osman S et al (2017) Effect of vitamin D replacement on cognition in multiple sclerosis patients. Sci Rep 7:45926. https:\/\/doi.org\/10.1038\/srep45926","journal-title":"Sci Rep"},{"key":"1509_CR82","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.2147\/NDT.S145614","volume":"13","author":"NN Yahno","year":"2017","unstructured":"Yahno NN, Fedotova AV (2017) Post-marketing observational program of the effectiveness of fluvoxamine for the treatment of depression in patients with neurological disorders: the FRIENDS study. Neuropsychiatr Dis Treat 13:2747\u20132756. https:\/\/doi.org\/10.2147\/NDT.S145614","journal-title":"Neuropsychiatr Dis Treat"},{"key":"1509_CR83","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.bbr.2018.11.005","volume":"359","author":"AR Chaves","year":"2019","unstructured":"Chaves AR, Wallack EM, Kelly LP et al (2019) Asymmetry of brain excitability: a new biomarker that predicts objective and subjective symptoms in multiple sclerosis. Behav Brain Res 359:281\u2013291. https:\/\/doi.org\/10.1016\/j.bbr.2018.11.005","journal-title":"Behav Brain Res"}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-020-01509-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13760-020-01509-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-020-01509-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T03:30:26Z","timestamp":1723692626000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13760-020-01509-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,29]]},"references-count":83,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1509"],"URL":"https:\/\/doi.org\/10.1007\/s13760-020-01509-w","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"value":"0300-9009","type":"print"},{"value":"2240-2993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,29]]},"assertion":[{"value":"30 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest. All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers\u2019 bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This manuscript does not contain clinical studies or patient data apart from those identified through literature search. No ethical approval was needed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}